Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
QuintilesIMS
Medtronic
Federal Trade Commission
Teva
Citi
Argus Health
AstraZeneca
Queensland Health

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CETIRIZINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Cetirizine Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00150761 Facial Thermography Study of Levocetirizine Versus Cetirizine Completed UCB Pharma Phase 4 Phase IV, human pharmacology, exploratory, randomized, 3-way (3 treatment periods) cross-over, double blind, double dummy, placebo controlled study to compare levocetirizine and cetirizine by means of IR thermography.
NCT00189397 Azathioprine Versus Corticosteroids in Parthenium Dermatitis Completed All India Institute of Medical Sciences, New Delhi N/A The dermatitis caused by the substances which come in contact with the skin is known as contact dermatitis. When such a reaction is caused by the agents suspended in the air, it is called air-borne contact dermatitis (ABCD). Parthenium hysterophorus at present is the commonest cause of ABCD in India though in some cases other plants have also been found to cause ABCD. Parthenium dermatitis is one of the major health problems in dermatology in our country. Though it has very little mortality, the disease normally continues to persist with variable remissions and relapses causing great distress and morbidity. Corticosteroids, topical and systemic have been the mainstay of the treatment so far. Therefore, the patients with ABCD who have to take corticosteroids for long periods of time tend to develop severe and sometimes irreversible side effects of the therapy. Azathioprine is an immunosuppressive drug which acts by inhibiting the T lymphocytes. In our previous studies we have been able to induce remissions in these patients with azathioprine used as daily as well as monthly bolus dose, without having to use systemic corticosteroids. The side effect with azathioprine in these studies were almost absent. We have therefore planned to study the therapeutic efficacy of azathioprine weekly pulse doses versus daily azathioprine in achieving remissions in patients having Parthenium dermatitis and to monitor the side effects of both the regimens.
NCT00253058 Study Of Perennial Allergic Rhinitis In Pediatrics Completed GlaxoSmithKline Phase 3 To verify of cetirizine dry syrup to ketotifen dry syrup in the change of total nasal symptom score (TNSS) over the total treatment period from the score of the baseline assessment period
NCT00257569 Study Of Atopic Dermatitis In Pediatrics Completed GlaxoSmithKline Phase 3 To verify of cetirizine dry syrup to ketotifen dry syrup in the change in the severity of pruritus of the treatment period.
NCT00257582 Study Of Cutaneous Disease Accompanied With Pruritus In Pediatrics Completed GlaxoSmithKline Phase 3 To assess the safety of long-term use of cetirizine dry syrup in children with various type of cutaneous disease accompanied on pruritus.
NCT00257595 Perennial Allergic Rhinitis In Pediatric Subjects Completed GlaxoSmithKline Phase 3 To assess the safety of long-term use of cetirizine dry syrup in children with perennial allergic rhinitis.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Cetirizine Hydrochloride

Condition Name

Condition Name for Cetirizine Hydrochloride
Intervention Trials
Allergic Rhinitis 10
Seasonal Allergic Rhinitis 8
Healthy 8
Rhinitis, Allergic, Seasonal 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cetirizine Hydrochloride
Intervention Trials
Rhinitis 32
Rhinitis, Allergic 31
Rhinitis, Allergic, Seasonal 14
Urticaria 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cetirizine Hydrochloride

Trials by Country

Trials by Country for Cetirizine Hydrochloride
Location Trials
United States 36
Canada 6
Germany 4
Japan 3
Italy 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cetirizine Hydrochloride
Location Trials
Texas 5
Maryland 4
North Carolina 3
Florida 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cetirizine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cetirizine Hydrochloride
Clinical Trial Phase Trials
Phase 4 18
Phase 3 16
Phase 2/Phase 3 1
[disabled in preview] 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cetirizine Hydrochloride
Clinical Trial Phase Trials
Completed 53
Not yet recruiting 5
Recruiting 4
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cetirizine Hydrochloride

Sponsor Name

Sponsor Name for Cetirizine Hydrochloride
Sponsor Trials
GlaxoSmithKline 12
UCB Pharma 6
Merck Sharp & Dohme Corp. 5
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cetirizine Hydrochloride
Sponsor Trials
Industry 56
Other 25
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
UBS
Accenture
Harvard Business School
Federal Trade Commission
Express Scripts
Covington
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.